Company Financials

CRISPR Therapeutics AG Financials

United States dollar

business CRISPR Therapeutics AG Company Profile

Main Stock Listing

NASDAQ: CRSP

Market Capitalization $5.12 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -12.39
Forward PE -12.06
Price to Sales TTM $133.66
Price to Book MRQ $2.63
Enterprise to Revenue 89.20
Enterprise to EBITDA -7.44

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -215.00%
Operating Margin -14854.78%
Return on Assets TTM -13.28%
Return on Equity TTM -25.33%

Income Statement

Revenue TTM $38,337,000
Revenue per Share TTM $0.44
Quarterly Revenue Growth 47.70%
Gross Profit TTM $-430,665,984
EBITDA $-459,481,984
Net Income to Common TTM $-488,296,992
Diluted EPS TTM $-5.54
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $1,915,709,952
Total Cash per Share MRQ $20.10
Total Debt MRQ $
Total Debt to Equity MRQ 11.01
Current Ratio MRQ 16.22
Book Value per Share MRQ $20.41

Cash Flow

Operating Cash Flow TTM $-302,492,000
Levered Free Cash Flow TTM $-206,821,744

CRSP Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 93,872,794
Float Shares 94,841,839
Avg 10 Volume 1,504,066
Avg 30 Volume None
Shares Short 21,863,725
Short Ratio 10.44
Short % of Shares 25.76%
% Held by Insiders 1.58%
% Held by Institutions 77.93%

Stock Price Summary

Beta 1.73
Fifty Two Week Low $30.04
Fifty Two Week High $78.48
Fifty Two Week Change 21.09%
Day 50 MA $56.79
Day 200 MA $51.52

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date